Latest News

Triple therapy revs up immune system against common brain tumor

A triple therapy for glioblastoma, including two types of immunotherapy and targeted radiation, has significantly prolonged the survival of mice with these brain cancers, according to a new report. Mice with implanted, mouse-derived glioblastoma cells lived an average of 67 days after the triple therapy, compared with mice that lasted 24 days when they received only the two immunotherapies.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Network measures predict neuropsychological outcome after brain injury

  • Evidence of genetic link to PTSD in soldiers exposed to childhood trauma

  • Size at birth affects risk of adolescent mental health disorders

  • First blood test to diagnose depression in adults

  • Smart teens rub off on teammates, study shows

  • Lack of facial expression leads to perceptions of unhappiness, new research shows

  • Entrepreneurs aren't overconfident gamblers, researchers say

  • Babies learn words differently as they age, researcher finds

  • Fighting parents hurt children's ability to recognize and regulate emotions

  • Power isn't enough: Study reveals missing link for effective leadership

  •